₁₇Hiroyuki Okada

Summary for 2004 [at-glance overview of Hiroyuki Okada work for the selected year as suggested by data mining algorithms]

This is an Authoratory overview of author Hiroyuki Okada. According to available data, in 2004 Hiroyuki Okada published at least 17 articles. This work was completed in collaboration with several authors including Mizuno, Motowo and Shiratori, Yasushi. Many other authors have collaborated with Hiroyuki Okada as well. There is no information about the funding or the grants awarded to support this work.

Hiroyuki Okada is a key opinion leader on Antigens, CD55, Chaperonin 60. This author's highest rank is 2 when compared to all other authors using the keyword Chaperonin 60. Analysis of the article abstracts and the titles suggests that Hiroyuki Okada professional interests are focused around "complement regulatory proteins", "gastric epithelial cells" and "serum daf concentrations". These might also be referred to as "helicobacter pylori", "malt lymphoma" or "decay-accelerating factor". Statistical analysis shows that Hiroyuki Okada's writing is likely to contains terms "pylori", "patients", "expression", "lymphoma", "cells" and "gastric".

The majority of Hiroyuki Okada articles are affiliated with Department of Pathology, Medicine and Medical Science (Medicine 1), Okayama University Graduate School of Medicine and Dentistry, 2-5-1 Shikata-cho, Okayama, 700-8558, Japan and Department of Medicine and Medical Science, Okayama University Graduate School of Medicine and Dentistry. Dentistry, Japan. Luckily, several email addresses are on file.

EN FR ES RU

Inaccurate information, needs improvement

make correction leave comment ask question

Images [images we found on the Internet for Hiroyuki Okada]

Do you know Hiroyuki Okada who matches the profile above? Click the photo and let us know!

Alternative names (1) [other authors with names similar to Hiroyuki Okada]

₂₇₆Okada, H

Year 2004 Charts [Hiroyuki Okada frequent coauthors and the most common unique vocabulary terms for the selected year]

Historical Performance Charts [graphical overview of Hiroyuki Okada publication and funding history for the range of years]

Emails (4) [email addresses extracted from Hiroyuki Okada affiliations]

hidden to prevent spam, click here to reveal

Hiroyuki Okada Coauthors (56) [all coauthors with the number of joint publications]

12

11

5

5

5

4

4

4

4

4

4

3

2

2

2

2

₃Futatsubashi, Masami

2

2

2

2

2

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

Other [context-specific ads]

Affiliations (7) [condensed summary of the Hiroyuki Okada affiliations, the leading number and the color conveys importance]

₇Department of Pathology, Medicine and Medical Science (Medicine 1), Okayama University Graduate School of Medicine and Dentistry, 2-5-1 Shikata-cho, Okayama, 700-8558, Japan.
₃Department of Medicine and Medical Science, Okayama University Graduate School of Medicine and Dentistry. Dentistry, Japan.
₂Positron Medical Center, Hamamatsu Medical Center, 5000 Hirakuchi, Hamakita 434-0041, Hamakita, Shizuoka, Japan.
₁Department of Internal Medicine, Nippon Kokan Fukuyama Hospital, Japan.
₁Laboratory of Biochemistry, Department of Biomedical Sciences, Graduate School of Veterinary Medicine, Hokkaido University, Sapporo 060-0818, Japan.
₁Department of Veterinary Internal Medicine, School of Veterinary Medicine, Rakuno Gakuen University, Ebetsu, Hokkaido, Japan.
₁Department of Microbiology, School of Pharmacy, Tokyo University of Pharmacy and Life Science, Tokyo 192-0392, Japan.

Key Opinion Leader In [Hiroyuki Okada is considered a key opinion leader in any keyword where the rank of 5 is achieved, the leading number before the keyword shows the author's rank as compared to all other authors]

₂Chaperonin 60 | ₃Antigens, CD55 | ₁₀Lymphoma, B-Cell, Marginal Zone | ₂₄Helicobacter pylori | ₃₅Colitis, Ulcerative | ₁₃₇Helicobacter Infections | ₂₇₉Anti-Bacterial Agents

Keywords (32) [keywords assigned to Hiroyuki Okada articles by PubMed, the leading number and the color conveys importance]

₁₄Humans | ₁₀Female | ₁₀Male | ₉Middle Aged | ₉Adult | ₈Aged | ₆Helicobacter pylori | ₄Antigens, CD55 | ₃RNA, Messenger | ₃Animals | ₃Aged, 80 and over | ₃Chaperonin 60 | ₃Colitis, Ulcerative | ₃Helicobacter Infections | ₃Anti-Bacterial Agents | ₃Lymphoma, B-Cell, Marginal Zone | ₃Molecular Sequence Data | ₃Amino Acid Sequence | ₂Base Sequence | ₂Recombinant Proteins | ₂Antigens, CD | ₂Biological Markers | ₂Gastric Mucosa | ₂Tomography, Emission-Computed | ₂Leukocytes, Mononuclear | ₂Radiopharmaceuticals | ₂Bacterial Proteins | ₂Polymerase Chain Reaction | ₂Immunohistochemistry | ₂Fluorodeoxyglucose F18 | ₂Cattle | ₂Reverse Transcriptase Polymerase Chain Reaction

Hiroyuki Okada Unique Vocabulary (96) [single words, word pairs and phrases obtained by analysis of abstracts and titles, the leading number and the color conveys importance; Hiroyuki Okada might be a good expert witness on these terms]

₄₀pylori | ₃₃patients | ₂₆expression | ₂₂lymphoma | ₂₁cells | ₂₀gastric | ₁₈daf | ₁₇helicobacter | ₁₄protein | ₁₄disease | ₁₃serum | ₁₂eradication | ₁₂malt | ₁₂factor | ₁₂cell | ₁₁increased | ₁₀hsp60 | ₁₀therapy | ₁₀significantly | ₁₀uc | ₉immune | ₉esophageal | ₈concentrations | ₈nora | ₈identified | ₈blood | ₈study | ₈decay-accelerating | ₇surface | ₇liver | ₇heat-shock | ₇responses
₁₃helicobacter pylori | ₁₁malt lymphoma | ₈decay-accelerating factor | ₇heat-shock protein | ₇pylori eradication | ₆lymphoid tissue | ₆ulcerative colitis | ₆daf concentrations | ₅juvenile polyps | ₅blood cells | ₅eradication therapy | ₅pylori hsp60 | ₅patients active | ₅genetic polymorphism | ₄focal fatty | ₄form pdp | ₄cell carcinoma | ₄concentrations surface | ₄pylori heat-shock | ₄esophageal squamous | ₄white blood | ₄mucosa-associated lymphoid | ₄primary form | ₄squamous cell | ₃nucleotide sequence | ₃lymphoma eradication | ₃inflammatory responses | ₃fatty liver | ₃expression nora | ₃immune responses | ₃gastric mucosa-associated | ₃response gastric
₅complement regulatory proteins | ₅gastric epithelial cells | ₅serum daf concentrations | ₄primary form pdp | ₄esophageal squamous cell | ₄pylori eradication therapy | ₄squamous cell carcinoma | ₄mucosa-associated lymphoid tissue | ₄white blood cells | ₄pylori heat-shock protein | ₄helicobacter pylori heat-shock | ₄surface daf expression | ₄beta genetic polymorphism | ₄lymphoid tissue malt | ₃expression nora genes | ₃gastric mucosa-associated lymphoid | ₃focal fatty liver | ₃mail mrna expression | ₃isolated patient gastric-mucosa-associated | ₃gastric malt lymphoma | ₃genotype cure rate | ₃human gastric epithelial | ₃pre-existing reflux esophagitis | ₃decay-accelerating factor cd55 | ₃patient gastric-mucosa-associated lymphoid-tissue | ₃gastric-mucosa-associated lymphoid-tissue lymphoma | ₂decay-accelerating factor complement-regulatory | ₂antibodies helicobacter pylori | ₂early therapy monitoring | ₂il-1 beta genetic | ₂europaeus agglutinin i-binding | ₂receptor-triggered pathway cultured

Reader's Comments (0) [comments posted by readers of Hiroyuki Okada profile]